The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 trial of pegzilarginase in patients (pts) with relapsed/refractory (R/R) AML or MDS refractory to hypomethylating agents (HMAs).
 
Geoffrey L. Uy
Consulting or Advisory Role - Curis; Glycomimetics; Jazz Pharmaceuticals; Novartis; Novo Nordisk; Pfizer
Travel, Accommodations, Expenses - Novartis
 
Michael R. Savona
Stock and Other Ownership Interests - Karyopharm Therapeutics
Consulting or Advisory Role - Amgen; ARIAD; Celgene; CTI; Gilead Sciences; Karyopharm Therapeutics
Research Funding - Astex Pharmaceuticals (Inst); Sunesis Pharmaceuticals (Inst); TG Therapeutics (Inst)
 
Benjamin K. Tomlinson
Consulting or Advisory Role - Foundation Medicine
 
Hetty Carraway
Honoraria - Agios; Baxalta; Celgene; Jazz Pharmaceuticals; Novartis
Consulting or Advisory Role - Agios; Baxalta; Celgene; Jazz Pharmaceuticals; Novartis
Speakers' Bureau - Agios; Baxalta; Celgene; Jazz Pharmaceuticals; Novartis
Research Funding - Celgene
Travel, Accommodations, Expenses - Agios; Baxalta; Celgene; Jazz Pharmaceuticals; Novartis
 
Dale L. Bixby
No Relationships to Disclose
 
Sarit E. Assouline
Consulting or Advisory Role - Janssen; Roche
Speakers' Bureau - Bristol-Myers Squibb; Pfizer
 
Joseph M. Brandwein
No Relationships to Disclose
 
Moshe Yair Levy
Stock and Other Ownership Interests - No specified
Honoraria - Amgen; ARIAD; Genentech; Janssen Biotech; Janssen Scientific Affairs; Millennium
Consulting or Advisory Role - E.R. Squibb Sons, LLC; Janssen Scientific Affairs; Novartis
Speakers' Bureau - Abbvie; Amgen; Bayer; Bristol-Myers Squibb; Genentech; Jazz Pharmaceuticals; Millennium
Research Funding - E.R. Squibb Sons, LLC; Millenium Pharamceuticals; Novartis; Pharmacyclics; Roche; Seagen
 
Robert Collins
Employment - University of Texas Southwestern Medical Center - Simmons Cancer Center
Honoraria - OptumHealth
Research Funding - Agios; Arog; Bristol-Myers Squibb; Celgene
 
Humberto Lara-Guerra
Employment - Aeglea Biotherapeutics
Stock and Other Ownership Interests - Aeglea Biotherapeutics
Patents, Royalties, Other Intellectual Property - MD Anderson Cancer Center
 
Susan Alters
Employment - Aeglea Biotherapeutics
Stock and Other Ownership Interests - Aeglea Biotherapeutics
 
Stephen Eckert
Employment - Acelity; Aeglea Biotherapeutics
Stock and Other Ownership Interests - Aeglea Biotherapeutics
Consulting or Advisory Role - Aeglea Biotherapeutics
Travel, Accommodations, Expenses - Aeglea Biotherapeutics
 
Scott Rowlinson
Employment - Aeglea Biotherapeutics
Leadership - Aeglea Biotherapeutics
Stock and Other Ownership Interests - Aeglea Biotherapeutics
Patents, Royalties, Other Intellectual Property - Aeglea Biotherapeutics
 
James Wooldridge
Employment - Aeglea Biotherapeutics; Lilly
Leadership - Aeglea Biotherapeutics
Stock and Other Ownership Interests - Aeglea Biotherapeutics; Lilly
 
Aaron David Schimmer
Leadership - Trillium Therapeutics
Stock and Other Ownership Interests - Bellicum Pharmaceuticals; Biospecifics Technologies ; Exelixis; GW Pharmaceuticals; NeuroDerm; Ocular Therapeutix; Rigel; Vanda Pharmaceuticals
Honoraria - Fluorinov Pharma; Trillium Therapeutics
Consulting or Advisory Role - Trillium Therapeutics
Research Funding - Aeglea Biotherapeutics; Takeda
Patents, Royalties, Other Intellectual Property - IP rights related to tigecycline